39.40
                                            
            Lineage Inc stock is traded at $39.40, with a volume of 1.05M.
            It is up +1.00% in the last 24 hours and up +1.99% over the past month.
            Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
        
        See More
    Previous Close:
              $39.02
            Open:
              $38.26
            24h Volume:
                1.05M
            Relative Volume:
              0.89
            Market Cap:
                $9.01B
            Revenue:
              $5.30B
            Net Income/Loss:
              $-624.00M
            P/E Ratio:
              -12.84
            EPS:
                -3.0692
            Net Cash Flow:
                $42.00M
            1W Performance:
              -3.12%
            1M Performance:
              +1.99%
            6M Performance:
                -18.29%
            1Y Performance:
              -46.77%
            Lineage Inc Stock (LINE) Company Profile
Name
                  
                      Lineage Inc
                    
                Sector
                  Industry
                  Phone
                  
                      (800) 678-7271
                    
                Address
                  
                      46500 HUMBOLDT DRIVE, NOVI
                    
                Compare LINE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                LINE
                            
                             Lineage Inc | 39.40 | 8.93B | 5.30B | -624.00M | 42.00M | -3.0692 | 
|   
                          
                                PLD
                            
                             Prologis Inc | 124.09 | 115.39B | 8.74B | 3.43B | 4.25B | 3.4347 | 
|   
                          
                                PSA
                            
                             Public Storage | 278.65 | 49.28B | 4.75B | 1.82B | 2.82B | 9.1652 | 
|   
                          
                                EXR
                            
                             Extra Space Storage Inc | 133.52 | 28.61B | 3.31B | 1.03B | 1.74B | 4.6014 | 
|   
                          
                                REXR
                            
                             Rexford Industrial Realty Inc | 41.28 | 9.62B | 903.94M | 275.97M | 94.31M | 1.23 | 
|   
                          
                                EGP
                            
                             Eastgroup Properties Inc | 174.53 | 9.37B | 679.77M | 236.60M | 385.49M | 4.6371 | 
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Aug-11-25 | Downgrade | BofA Securities | Buy → Underperform | 
| Jul-01-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight | 
| Jun-23-25 | Downgrade | JP Morgan | Neutral → Underweight | 
| Jun-23-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight | 
| Jun-12-25 | Downgrade | BNP Paribas Exane | Neutral → Underperform | 
| May-06-25 | Downgrade | BofA Securities | Buy → Neutral | 
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform | 
| Mar-28-25 | Initiated | Citigroup | Neutral | 
| Jan-14-25 | Initiated | Exane BNP Paribas | Neutral | 
| Dec-20-24 | Downgrade | JP Morgan | Overweight → Neutral | 
| Sep-18-24 | Initiated | CapitalOne | Overweight | 
| Sep-16-24 | Initiated | CapitalOne | Overweight | 
| Aug-19-24 | Initiated | Deutsche Bank | Hold | 
| Aug-19-24 | Initiated | Evercore ISI | In-line | 
| Aug-19-24 | Initiated | Goldman | Buy | 
| Aug-19-24 | Initiated | JP Morgan | Overweight | 
| Aug-19-24 | Initiated | KeyBanc Capital Markets | Overweight | 
| Aug-19-24 | Initiated | Mizuho | Neutral | 
| Aug-19-24 | Initiated | Morgan Stanley | Overweight | 
| Aug-19-24 | Initiated | Piper Sandler | Overweight | 
| Aug-19-24 | Initiated | Robert W. Baird | Outperform | 
| Aug-19-24 | Initiated | Scotiabank | Sector Outperform | 
| Aug-19-24 | Initiated | Truist | Buy | 
| Aug-19-24 | Initiated | UBS | Neutral | 
| Aug-19-24 | Initiated | Wells Fargo | Equal Weight | 
                    View All
                     
                  
                Lineage Inc Stock (LINE) Latest News
What earnings revisions data tells us about Lineage Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com
How to recover losses in Lineage Inc. stockCPI Data & High Return Stock Watch Alerts - newser.com
How Lineage Inc. stock performs in interest rate cycles2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Will Lineage Inc. stock benefit from upcoming earnings reportsLayoff News & Scalable Portfolio Growth Methods - newser.com
Will a bounce in Lineage Inc. offer an exitMarket Activity Recap & Safe Entry Trade Reports - newser.com
What margin trends mean for Lineage Inc. stockJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Lineage (LINE): Valuation in Focus as Analyst Outlook and Earnings Anticipation Shape Investor Sentiment - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 - Investing News Network
When is the best time to exit Lineage Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 Growth vs Value & Technical Pattern Recognition Alerts - newser.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profilePortfolio Gains Summary & Daily Price Action Insights - newser.com
Why analysts upgrade Lineage Inc. stock2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Volume spikes in Lineage Inc. stock – what they mean2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Ethic Inc. Acquires New Holdings in Lineage, Inc. $LINE - MarketBeat
How Lineage Cell Therapeutics Inc. stock reacts to Fed tighteningWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com
Can Lineage Inc. recover in the next quarterWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Using R and stats models for Lineage Inc. forecastingBond Market & Fast Entry Momentum Trade Alerts - newser.com
How institutional buying supports Lineage Cell Therapeutics Inc. stock2025 Retail Activity & Growth Focused Investment Plans - Fundação Cultural do Pará
How Lineage Inc. stock compares to growth peers2025 Key Highlights & Growth Focused Entry Reports - Fundação Cultural do Pará
How resilient is Lineage Inc. stock in market downturnsJuly 2025 Setups & Free High Return Stock Watch Alerts - Fundação Cultural do Pará
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect - ACCESS Newswire
Barclays Lowers the PT on Lineage, Inc. (LINE), Keeps a Buy Rating - MSN
Is Lineage Cell Therapeutics Inc. stock a momentum leaderPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock a fit for income portfoliosRecession Risk & Reliable Breakout Stock Forecasts - Fundação Cultural do Pará
Is Lineage Cell Therapeutics Inc. stock a top pick in earnings seasonMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Will Lineage Cell Therapeutics Inc. stock benefit from commodity pricesTake Profit & Free Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Will Lineage Inc. stock deliver better than expected guidanceQuarterly Growth Report & Low Drawdown Trading Techniques - Fundação Cultural do Pará
Lineage’s Cold-Storage Empire Struggles To Defrost Its Stock Price - Finimize
Will Lineage Inc. stock benefit from infrastructure spendingWatch List & Safe Entry Point Identification - newser.com
Chilton Capital Management LLC Purchases New Shares in Lineage, Inc. $LINE - MarketBeat
Why hedge funds are buying Lineage Cell Therapeutics Inc. stockJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Investors to Connect - ACCESS Newswire
Lineage Inc Stock (LINE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lineage Inc Stock (LINE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | 
|---|---|---|---|---|---|---|---|
| Thattai Sudarsan V | See Remarks | Aug 08 '25 | Buy | 42.45 | 3,563 | 151,238 | 7,983 | 
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN | Aug 08 '25 | Buy | 42.28 | 23,540 | 995,216 | 62,323 | 
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN | May 09 '25 | Buy | 45.63 | 11,050 | 504,187 | 38,783 | 
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN | May 08 '25 | Buy | 44.93 | 10,949 | 491,921 | 35,266 | 
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN | May 06 '25 | Buy | 43.75 | 11,500 | 503,074 | 27,733 | 
| Thattai Sudarsan V | See Remarks | May 05 '25 | Buy | 45.23 | 4,420 | 199,908 | 4,420 | 
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN | Feb 28 '25 | Buy | 60.50 | 24,317 | 1,471,144 | 24,317 | 
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN | Feb 28 '25 | Buy | 60.51 | 16,233 | 982,229 | 16,233 | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App